Home  >  Products  >  VKORC1 (vitamin K epoxide reductase complex, subunit 1 ) Blocking Peptide (the N terminal of VKORC1)(100ug)
VKORC1 (vitamin K epoxide reductase complex, subunit 1 ) Blocking Peptide (the N terminal of VKORC1)(100ug)

VKORC1 (vitamin K epoxide reductase complex, subunit 1 ) Blocking Peptide (the N terminal of VKORC1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NAGA Antibody (ARP63321_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63321
Size: 100ug
Weight: 45kDa
Gene: 4668
Format: Lyophilized powder
Target: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Alternative names: D22S674; GALB
See Full Product Listings >